Patent · US Active

Ocular implant made by a double extrusion process

US8048445B2 · kind B2 · utility

13Cited by
21References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 15, 2008
Grant dateNov 1, 2011
Priority date
Expiry dateJul 15, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/204
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.